Overview
Dr. Claire Hoppenot is a gynecologic oncologist who specializes in surgery and chemotherapy for patients with cancers of the ovary and fallopian tube, sarcomas and endometrial cancers of the uterus, and cervical, vulvar and vaginal cancers. She is an Assistant Professor of Gynecologic Oncology at the Dan L Duncan Comprehensive Cancer Center Gynecologic Oncology at Baylor College of Medicine.Dr. Hoppenot’s clinical and research interests include: Minimally-invasive and robotic surgery; treatment of uterine, cervical, ovarian, fallopian tube, vulvar, and vaginal cancers, uterine sarcoma, and pre-invasive disease; screening and risk-reduction of women at high risk of gynecologic cancers; surgical and medical education; complex gynecologic surgery; clinical medical ethics; and clinical trials.She has also participated in developing guidelines for the use of heated intraperitoneal chemotherapy for ovarian cancers and research interviewing women with advanced ovarian cancers to compile patterns in patient concerns that could be addressed more frequently in a patient-physician relationship.Dr. Hoppenot received her undergraduate degree from Princeton University and her medical degree from Jefferson Medical College in Philadelphia, Pennsylvania. She completed her residency in obstetrics and gynecology at Northwestern University Feinberg School of Medicine in Chicago and a clinical fellowship in gynecologic oncology at The University of Chicago Pritzker School of Medicine.Dr. Hoppenot is a member of the Society for Gynecologic Oncology and the American Society of Clinical Oncology.In addition to English, Dr. Hoppenot speaks Spanish, French, and Portuguese.
Dr. Hoppenot is rated as an Experienced provider by MediFind in the treatment of Gestational Trophoblastic Disease. Her top areas of expertise are Cervical Cancer, Ovarian Cancer, Hydatidiform Mole, Gestational Trophoblastic Disease, and Oophorectomy.
Her clinical research consists of co-authoring 18 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Gestational Trophoblastic Disease.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1919 Old Spanish Trail, 7th Floor, Houston, TX 77054
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Baylor College Of Medicine - Dan L Duncan Comprehensive Cancer Center: Gynecologic Oncology
Dr. Jan Sunde is an oncologist specializing in gynecologic oncology. He is an Associate Professor of Gynecologic Oncology and the Division Director and Medical Director of Gynecologic Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Sunde’s clinical and research interests include: clinical trials; minimally invasive surgery for gynecologic cancers; sentinel lymph node mapping for gynecologic cancers; treatment of uterine, cervical, ovarian, vulvar and vaginal cancers and preinvasive diseases; screening and risk-reduction of women at high risk of gynecologic cancers; surgical and medical education; complex gynecologic surgery; treatment of uterine sarcoma and gestational trophoblastic neoplasia; and basic science research investigating the origin of ovarian cancer.Dr. Sunde received a B.S. from the University of Washington - Seattle and his medical degree from the Texas Tech University Health Sciences Center in Lubbock, Texas. He completed his residency at Texas Tech University Health Sciences Center in El Paso. He completed clinical fellowships in gynecologic oncology at The Norwegian Radium Hospital in Oslo, Norway and at the Walter Reed Army Medical Center in Washington, D.C.Dr. Sunde is board-certified in Gynecologic Oncology and Obstetrics and Gynecology by the American Board of Obstetrics and Gynecology. Dr. Sunde is a member of the Society of Gynecologic Oncologists, American Society of Clinical Oncology, and the International Gynecologic Cancer Society. In addition to English, Dr. Sunde speaks Norwegian and Spanish. Dr. Sunde is rated as an Experienced provider by MediFind in the treatment of Gestational Trophoblastic Disease. His top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Gestational Trophoblastic Disease, and Ovarian Cancer.
Utmb Faculty Group Practice
Otto Pantoja is an Obstetrics and Gynecologist in Webster, Texas. Dr. Pantoja is rated as an Advanced provider by MediFind in the treatment of Gestational Trophoblastic Disease. His top areas of expertise are Vaginal Bleeding Between Periods, Hydatidiform Mole, Gestational Trophoblastic Disease, Intrauterine Device Insertion, and Salpingo-Oophorectomy. Dr. Pantoja is currently accepting new patients.
Ignatia Van Den Veyver is a Neonatologist and an Obstetrics and Gynecologist in Houston, Texas. Dr. Van Den Veyver is rated as an Advanced provider by MediFind in the treatment of Gestational Trophoblastic Disease. Her top areas of expertise are Hydatidiform Mole, Focal or Multifocal Malformations in Neuronal Migration, Ectodermal Dysplasias, and Clouston Syndrome. Dr. Van Den Veyver is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cervical CancerDr. Hoppenot isExperienced. Learn about Cervical Cancer.
- Cervical DysplasiaDr. Hoppenot isExperienced. Learn about Cervical Dysplasia.
- Endometrial CancerDr. Hoppenot isExperienced. Learn about Endometrial Cancer.
- Endometrial Stromal SarcomaDr. Hoppenot isExperienced. Learn about Endometrial Stromal Sarcoma.
- Gestational Trophoblastic DiseaseDr. Hoppenot isExperienced. Learn about Gestational Trophoblastic Disease.
- Hydatidiform MoleDr. Hoppenot isExperienced. Learn about Hydatidiform Mole.